Patients and methods Seventeen children with non-tuberculous mycobacterial lymphadenopathy seen in the Newcastle area between 1989 and 1993, were reviewed. Fifteen were identified from culture reports from the Regional Tuberculosis Laboratory, two from the presence of acid fast bacilli on histology together with differential skin testing.
Results
There were 12 girls and five boys, aged 6 months to 8 5 years (mean 3 2 years); all were 
Abstract
The surgical and antimicrobial treatment of non-tuberculous mycobacterial lymphadenopathy in 17 children was reviewed. Node excision was curative, but most nodes were still incised leaving discharging lesions. Standard antituberculous treatment was unhelpful, but a new macrolide/quinolone combination appeared to be effective in three cases. Non-tuberculous mycobacteria, usually harmless commensals, occasionally produce disease or latent infection in children, most commonly cervical lymphadenopathy. The differential diagnosis includes bacterial abscess, tuberculosis, and malignancy. The dilemma for clinicians is to distinguish tuberculous from non-tuberculous mycobacterial infection, as treatment differs.
culous chemotherapy both required further surgical excision. The remaining three receiving antituberculous treatment had less severe induration initially and had healed satisfactorily by one year.
Discussion
Our series reaffirms the excellent outcome when the node is excised.1 2 Unfortunately incision and drainage remains the most common surgical intervention; this increases the risk of sinus formation and discharge, producing scarring and a poor cosmetic outcome.
Early diagnosis from recognition of the clinical features with or without differential skin testing might ensure node excision. Culture of fine needle aspirates is of little help as later excision may be made more difficult. Differential skin testing with atypical mycobacteria purified protein derivative has been investigated3; we suggest this is useful, although there can be cross reactivity between mycobacteria, sensitivity and specificity are not defined, and the reagents are not commercially available at the moment. All those tested in this study had positive results, although two also gave positive Mantoux responses. Further work is needed to see if they are indeed useful in diagnosis.
Treatment remains a problem for nodes which are difficult to excise; standard antituberculous drugs have little effect on nontuberculous mycobacteria, which are usually highly resistant, and so should no longer be prescribed.' 2 Studies on bacteraemia caused by nontuberculous mycobacteria in patients with AIDS4 and in vitro studies suggest azithromycin and clarithromycin may be beneficial.5 Although not licensed for this indication in children, the safety profiles and side effects of the new macrolides and quinolones make them acceptable for use in non-tuberculous mycobacterial lymphadenopathy, and individual clinicians are using them.6 In our small series we gained an impression that they enhanced resolution and healing.
A larger, multicentre study, is needed to see whether these new regimens are truly effective both as a rescue treatment postoperatively and in treating disease not amenable to surgery. Until all non-tuberculous mycobacterial nodes are excised the search for effective drug treatment continues. 
